ReviewCurrent opinion in oncology2022

Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations.

Natalie Y L Ngoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.